Haddock Jason

CFO at ARRAY BIOPHARMA INC

Sold, on record
$2.9M
Dollars the filings state
Form 4 sales
4
Latest Feb 7, 2019
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale ARRAY BIOPHARMA INCPlan not stated
    Jan 16 2018

    Sold 7,500 shares at $13.73 ($103k)

    Haddock Jason, CFO

    Sold 20.6% of holdings ($499k position)28,868 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale ARRAY BIOPHARMA INCUnusual
    Jul 30 +195 days

    Sold 25,000 shares at $14.87 ($372k)

    Haddock Jason, CFO

    Sold 31.1% of holdings ($1.2M position)55,393 shares leftFiling

  3. 3 Form 4 sale ARRAY BIOPHARMA INCUnusual
    Aug 15 +16 days

    Sold 20,000 shares at $13.92 ($278k)

    Haddock Jason, CFO

    Sold 36.1% of holdings ($771k position)35,393 shares leftFiling

  4. 4 Form 4 sale ARRAY BIOPHARMA INCUnusual
    Feb 7 +176 days

    Sold 96,712 shares at $21.80 ($2.1M)

    Haddock Jason, CFO

    Sold 76.3% of holdings ($2.8M position)30,059 shares left4.8x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (4)

Form 144 notices and Form 4 sales by Haddock Jason
Source
Feb 7, 2019ARRAY BIOPHARMA INCCFOForm 4 sale96,712$2.1M76.3%UnusualSEC
Aug 15, 2018ARRAY BIOPHARMA INCCFOForm 4 sale20,000$278k36.1%UnusualSEC
Jul 30, 2018ARRAY BIOPHARMA INCCFOForm 4 sale25,000$372k31.1%UnusualSEC
Jan 16, 2018ARRAY BIOPHARMA INCCFOForm 4 sale7,500$103k20.6%Plan not statedSEC